Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...
In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...
Eli Lilly, which manufacturers Mounjaro and Zepbound, announced six new lawsuits against compounding pharmacies ... legal ...
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.